Posted On: 01/15/2014 8:59:43 AM
Post# of 99202
$NVLX's Dr. Mark L. Rabe, Chairman of the Scientific Advisory Board (SAB) of its wholly-owned subsidiary Medical Marijuana Sciences, Inc., has developed a Charter and Goals and Objectives for that Board.
The charter developed by Dr. Rabe delineates the mission of the SAB as follows:
Developing disease treatments that utilize constituents of Cannabis through the use of Nuvilex's proprietary Cell-in-a-Box(TM) cellulose-based live-cell encapsulation technology. Initial emphasis will be placed on the development of treatments for brain and pancreatic cancers, two of the deadliest and most difficult-to-treat forms of the disease; and
Establishing Medical Marijuana Sciences as an industry leader in the development of Cannabis-based disease treatments.
The Charter presents the Goals and Objectives of the SAB in advising Medical Marijuana Sciences as a whole. They are:
Provide an objective and diversified perspective on the science and technology related to the use of Cannabis for treatments of diseases;
Assist in drug development and clinical research;
Validate the science and technology;
Assist in developing a pipeline of products;
Establish critical connections with academic research; and
Evaluate new technologies and intellectual properties and assess the market potential of each as they relate to the Charter of Medical Marijuana Sciences.
In addition to developing the SAB Charter, Dr. Rabe has begun to recruit individuals worldwide with stellar credentials to become members of the SAB of Medical Marijuana Sciences. If these recruitment efforts are successful, the SAB will be diverse in terms of both outlook and expertise.
(0)
(0)
